Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['avastin', 'imfinzi', 'ovarian', 'brca', 'lynparza', '$azn']
$azn teases out an unusual win for lynparza + imfinzi + avastin + chemo in 1l brca+ve ovarian cancer maintenance, but does pd-1 actually add anything? via from #asco23 -&gt; 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.